Arcellx
$114.8
34
+$0.08+0.07% Tuesday 20:00
Statistics
Day High
114.84
Day Low
114.72
52W High
114.94
52W Low
47.86
Volume
645,756
Avg. Volume
2,266,950
Mkt Cap
6.71B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
7MayExpected
Expected EPS
-1.108689
Actual EPS
N/A
Financials
-1,027.25%Profit Margin
Unprofitable44.57MRevenue
-457.87MNet Income
Analyst Ratings
$116.82Average Price Target
The highest estimate is 130.00.
From 13 ratings within the last 6 months. This is not an investment recommendation.
From 13 ratings within the last 6 months. This is not an investment recommendation.
Buy 8%
Hold 92%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ACLX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap4.75B
Allogene Therapeutics
ALLO
Mkt Cap604.57M
Gilead Sciences
GILD
Mkt Cap173.41B
Novartis
NVS
Mkt Cap297.32B
Precigen
PGEN
Mkt Cap1.39B
Sangamo Therapeutics
SGMO
Mkt Cap124.32M
Fate Therapeutics
FATE
Mkt Cap141.84M
About
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent SparX proteins targeting BCMA to treat r/r MM; ACLX-002 and ACLX-003 for treating r/r acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS); and other AML/MDS product candidates, as well as solid tumor programs. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Gaithersburg, Maryland.
Show more...
CEO
Mr. Rami Elghandour
Employees
163
Country
US
ISIN
US03940C1009
Listings
0 Comments
Share your thoughts
FAQ
What is Arcellx stock price today?▼
The current price of ACLX is $114.8 USD — it has increased by +0.07% in the past 24 hours. Watch Arcellx stock price performance more closely on the chart.
What is Arcellx stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Arcellx stocks are traded under the ticker ACLX.
Is Arcellx stock price growing?▼
ACLX stock has risen by +0.04% compared to the previous week, the month change is a +0.41% rise, over the last year Arcellx has showed a +114.18% increase.
What is Arcellx market cap?▼
Today Arcellx has the market capitalization of 6.71B
When is the next Arcellx earnings date?▼
Arcellx is going to release the next earnings report on May 07, 2026.
What were Arcellx earnings last quarter?▼
ACLX earnings for the last quarter are -1.06 USD per share, whereas the estimation was -1.04 USD resulting in a -2.18% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Arcellx revenue for the last year?▼
Arcellx revenue for the last year amounts to 44.57M USD.
What is Arcellx net income for the last year?▼
ACLX net income for the last year is -457.87M USD.
How many employees does Arcellx have?▼
As of April 08, 2026, the company has 163 employees.
In which sector is Arcellx located?▼
Arcellx operates in the Health Care sector.
When did Arcellx complete a stock split?▼
Arcellx has not had any recent stock splits.
Where is Arcellx headquartered?▼
Arcellx is headquartered in Redwood City, US.